These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16599262)

  • 61. Comparative binding and disintegrating property of Echinochloa colona starch (difra starch) against maize, sorghum, and cassava starch.
    Abdallah DB; Charoo NA; Elgorashi AS
    Pharm Biol; 2014 Aug; 52(8):935-43. PubMed ID: 24552302
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multivariate analysis of relationships between material properties, process parameters and tablet tensile strength for alpha-lactose monohydrates.
    Haware RV; Tho I; Bauer-Brandl A
    Eur J Pharm Biopharm; 2009 Nov; 73(3):424-31. PubMed ID: 19698784
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimization of a matrix tablet formulation using a mixture design.
    Waaler PJ; Graffner C; Müller BW
    Acta Pharm Nord; 1992; 4(1):9-16. PubMed ID: 1515056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acid-treated yeast cell wall as a binder displaying function of disintegrant.
    Ozeki T; Katsuyama H; Yasuzawa Y; Takashima Y; Kasai T; Eguchi T; Kakiuchi H; Yuasa H; Okada H
    AAPS PharmSciTech; 2003; 4(3):E41. PubMed ID: 14621973
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
    Rojas J; Guisao S; Ruge V
    AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improvement of mechanical properties of pellet containing tablets by thermal treatment.
    Csobán Z; Kállai-Szabó B; Kállai-Szabó N; Sebe I; Gordon P; Antal I
    Int J Pharm; 2015 Dec; 496(2):489-96. PubMed ID: 26475969
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches.
    Odeku OA; Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Sep; 70(1):357-71. PubMed ID: 18562187
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential of carnuba wax in ameliorating brittle fracture during tableting.
    Uhumwangho MU; Okor RS; Adogah JT
    Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Considerations about the theoretically expected crushing strength of tablets from binary powder mixtures: double layer tablets versus arithmetic additivity rule.
    Belda PM; Mielck JB
    Eur J Pharm Biopharm; 2006 Nov; 64(3):343-50. PubMed ID: 16914296
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of force feeder on tablet strength during compression.
    Narang AS; Rao VM; Guo H; Lu J; Desai DS
    Int J Pharm; 2010 Nov; 401(1-2):7-15. PubMed ID: 20816733
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A study of physicochemical and biopharmaceutical properties of amoxicillin tablets using full factorial design and PCA biplot.
    Pasqualoto KF; Teófilo RF; Guterres M; Pereira FS; Ferreira MM
    Anal Chim Acta; 2007 Jul; 595(1-2):216-20. PubMed ID: 17606003
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The use of semi-synthetic polymers in the formulation of sucking and chewable tablets containing sage extract and zinc gluconate].
    Linka WA; Golenia E; Zgoda MM; Kołodziejczyk MK
    Polim Med; 2014; 44(4):237-45. PubMed ID: 25932905
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An investigation of the influence of the core material properties on the compression and properties of dry-coated tablets.
    Thomas WI; Rowley G; Doveston G
    Drug Dev Ind Pharm; 1998 Oct; 24(10):973-8. PubMed ID: 9876552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents.
    Murugaiyah V; Chan KL
    J Ethnopharmacol; 2009 Jul; 124(2):233-9. PubMed ID: 19397979
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation and Comparison of Three Types of Spray Dried Coprocessed Excipient Avicel® for Direct Compression.
    Vodáčková P; Vraníková B; Svačinová P; Franc A; Elbl J; Muselík J; Kubalák R; Solný T
    Biomed Res Int; 2018; 2018():2739428. PubMed ID: 29850496
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.
    Mishra DN; Bindal M; Singh SK; Vijaya Kumar SG
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):99-102. PubMed ID: 16394558
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A study of a novel coprocessed dry binder composed of α-lactose monohydrate, microcrystalline cellulose and corn starch.
    Mužíková J; Srbová A; Svačinová P
    Pharm Dev Technol; 2017 Dec; 22(8):964-971. PubMed ID: 26758475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.